Log in
(Ad)
A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

NYSE:VAR - Varian Medical Systems Stock Price, Forecast & News

$149.57
+1.50 (+1.01 %)
(As of 01/23/2020 07:07 AM ET)
Today's Range
$148.07
Now: $149.57
$150.06
50-Day Range
$138.49
MA: $143.69
$149.57
52-Week Range
$103.92
Now: $149.57
$150.06
Volume766,822 shs
Average Volume435,405 shs
Market Capitalization$13.60 billion
P/E Ratio44.38
Dividend YieldN/A
Beta0.89
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP92220P10
Phone650-493-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.23 billion
Cash Flow$5.75 per share
Book Value$19.52 per share

Profitability

Net Income$291.90 million

Miscellaneous

Employees10,062
Market Cap$13.60 billion
Next Earnings Date1/29/2020 (Confirmed)
OptionableOptionable

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

One of the best ways to double, if not triple your investment in 2020 will be found in tech stocks. Especially those involved with the 5G rollout, where we're still finding undervalued opportunities. In our latest special report, we detail these and other hot tech stocks that should be part of your portfolio right now.

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its earnings results on Wednesday, October, 23rd. The medical equipment provider reported $1.21 EPS for the quarter, meeting analysts' consensus estimates of $1.21. The medical equipment provider had revenue of $878.90 million for the quarter, compared to analysts' expectations of $858.47 million. Varian Medical Systems had a return on equity of 24.48% and a net margin of 9.65%. The company's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.16 earnings per share. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Varian Medical Systems.

How can I listen to Varian Medical Systems' earnings call?

Varian Medical Systems will be holding an earnings conference call on Wednesday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $5.30-5.45 for the period, compared to the Thomson Reuters consensus estimate of $5.40. The company issued revenue guidance of $$3.515-3.612 billion, compared to the consensus revenue estimate of $$3.57 billion.

What price target have analysts set for VAR?

8 equities research analysts have issued 1-year price objectives for Varian Medical Systems' shares. Their forecasts range from $130.00 to $165.00. On average, they anticipate Varian Medical Systems' stock price to reach $150.50 in the next twelve months. This suggests a possible upside of 0.6% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.

What is the consensus analysts' recommendation for Varian Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. A solid guidance for fiscal 2020 paints a bright picture as well. Expansion in gross and operating margins is an added positive. The stock has outperformed the industry in a year’s time. Varian exited the fiscal fourth quarter on a strong note. On the flip side, the Proton Solutions unit saw a soft quarter. Moreover, Varian’s APAC revenues were hurt by headwinds in Japan." (1/20/2020)
  • 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)
  • 3. BTIG Research analysts commented, "For its fiscal first quarter, Varian again outperformed on two key metrics: revenue and Oncology gross orders. Revenue of $741.0M topped consensus by ~$20M while Oncology gross orders of $716.5M was ~$60M above estimates. We like that Oncology gross order growth of +17% y/y CC was the highest in a decade and that the strength came from all regions. Still, with VAR shares trading near all-time historical highs, investors were likely seeking perfection. VAR may trade up Thursday, but with gross margins and operating margins coming in below consensus models, we think the positive stock reaction may be just a few dollars." (1/24/2019)

Has Varian Medical Systems been receiving favorable news coverage?

Press coverage about VAR stock has trended somewhat negative recently, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Varian Medical Systems earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Varian Medical Systems.

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,660,000 shares, a decrease of 15.7% from the December 15th total of 1,970,000 shares. Based on an average trading volume of 630,000 shares, the short-interest ratio is presently 2.6 days. Currently, 1.8% of the company's shares are short sold. View Varian Medical Systems' Current Options Chain.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Netflix (NFLX), Visa (V), Verizon Communications (VZ), Alibaba Group (BABA), AT&T (T), Thermo Fisher Scientific (TMO), CVS Health (CVS), Align Technology (ALGN) and Illumina (ILMN).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.52%), DNB Asset Management AS (0.15%), Zurcher Kantonalbank Zurich Cantonalbank (0.14%), Nisa Investment Advisors LLC (0.05%), Johanson Financial Advisors Inc. (0.05%) and Assenagon Asset Management S.A. (0.04%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Commerzbank Aktiengesellschaft FI, Raymond James Trust N.A., Webster Bank N. A. and IFM Investors Pty Ltd. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was acquired by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Johanson Financial Advisors Inc., Assenagon Asset Management S.A., Boston Trust Walden Corp, Tower View Investment Management & Research LLC, We Are One Seven LLC, Exchange Traded Concepts LLC and Canandaigua National Bank & Trust Co.. View Insider Buying and Selling for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $149.57.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $13.60 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.View Additional Information About Varian Medical Systems.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is http://www.varian.com/.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]


MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  507 (Vote Outperform)
Underperform Votes:  445 (Vote Underperform)
Total Votes:  952
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel